Chindex (CHDX) Receives Key China Approvals

July 3, 2008 7:05 AM EDT

Chindex International, Inc. (Nasdaq: CHDX) received long-awaited approval from the State Food and Drug Administration of the People's Republic of China to introduce new products, including the daVinci S Surgical System manufactured by Intuitive Surgical (Nasdaq: ISRG) and the AlexLaser manufactured by Candela Corporation (Nasdaq: CLZR).

The receipt of the SFDA Certificates will allow Chindex to begin the sales process and launch official marketing programs for these products, creating a wealth of new market opportunities for the Company.


Related Categories

Corporate News
FDA

Stocks Mentioned

CHDX 8.66

-1.08 -11.09%
Volume: 206,869
Track CHDX

CLZR 1.80

-0.22 -10.89%
Volume: 818,070
Track CLZR

ISRG 197.12

-28.58 -12.66%
Volume: 1,993,504
Track ISRG


Add Your Comment